Skip to main content

Select a country

Home
About Accord
Company Purpose

Global Presence

Corporate Responsibility
Products & Services
Product Portfolio

Oncology & Haematology

Critical Care

Autoimmune

Central Nervous System
Careers
High Tech
News & Media
Contact
Report a Side Effect
Select a country
Austria

Czech Republic

Finland

France

Germany

Ireland

Italy

Netherlands

Poland

Romania

Slovakia

Spain

Sweden

UK

USA

Zubsolv▼ (Buprenorphine Naloxone)

Spec Brand

Summaries of Product Characteristics (SPCs)

DOWNLOAD SPC Zubsolv 1.4mg/0.36 mg, 2.9mg/0.71mg, 5.7mg/1.4mg, 8.6mg/2.1mg, 11.4mg/2.9mg sublingual tablets Download

Patient Information Leaflets (PILs)

DOWNLOAD PIL Zubsolv 1.4mg/0.36 mg, 2.9mg/0.71mg, 5.7mg/1.4mg, 8.6mg/2.1mg, 11.4mg/2.9mg sublingual tablets Download

Patient Information Leaflets (PILs)

DOWNLOAD PIL Zubsolv 1.4mg/0.36 mg, 2.9mg/0.71mg, 5.7mg/1.4mg, 8.6mg/2.1mg, 11.4mg/2.9mg sublingual tablets Download

Are you an Irish healthcare professional?

I’m an Irish Healthcare Professional Please click here to confirm that you are an Irish Healthcare Professional. This section of the accord-healthcare.ie site is intended for Irish Healthcare Professionals only. I’m a member of the Public Please click here if you are a member of the public to return to the public page of accord-healthcare.ie I’m a Patient Please click here if you are a member of the public that has been prescribed an Accord product

Competition Law
|
Modern Slavery Act
|
Legal Notices
|
Cookies Policy
|
Privacy Policy
|
Transfers of Value

Job code: ??? | Date of last revision ???

Speak Up Hotline

© Copyright Accord Healthcare 2024

Select your country:

Please confirm you are a HCP before continuing with this download.